Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China

LOS ANGELES & CASTRES, France--(BUSINESS WIRE)--Puma Biotechnology and Pierre Fabre added Greater China to their license agreement. Puma and CANbridge Pharma terminated their Greater China agreement

Click to view original post